Melanoma is the most common type of eye tumor. Proton therapy has been used to treat melanoma without removing the eye and with less damage to the cornea, lens, retina, fovea or optic nerve since the 1970s. Protons can be controlled with greater precision than X-rays, meaning that more energy goes into destroying the tumor and less radiation is delivered to surrounding tissue.1
Studies show that patients treated with protons have long-term survival rates equal to that of patients who have had an eye removed.2 Furthermore, most patients in these studies have retained useful vision in the treated eye.2
Request more information or call 877.887.5807 to learn if you can benefit from proton therapy.